Literature DB >> 12020262

Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

Patrizia Mecocci1, M Cristina Polidori, Antonio Cherubini, Tiziana Ingegni, Paola Mattioli, Marco Catani, Patrizia Rinaldi, Roberta Cecchetti, Wilhelm Stahl, Umberto Senin, M Flint Beal.   

Abstract

CONTEXT: A large body of experimental evidence suggests that in Alzheimer disease (AD) pathogenesis an important role is played by oxidative stress, but there is still a lack of data on in vivo markers of free radical-induced damage.
OBJECTIVES: To evaluate levels of 8-hydroxy-2'-deoxyguanosine (8-OHdG), a marker of oxidative damage to DNA, in peripheral lymphocytes; to measure plasma concentrations of several nonenzymatic antioxidants; and to assess the relationships between any observed changes in lymphocyte DNA 8-OHdG content and plasma antioxidant levels in patients with AD and healthy aged control subjects.
SUBJECTS: Forty elderly outpatients with AD and 39 healthy age- and sex-matched controls were studied. MAIN OUTCOME MEASURES: The level of 8-OHdG was determined in DNA extracted from lymphocytes and plasma levels of vitamin C, vitamin A, vitamin E, and carotenoids (zeaxanthin, beta-cryptoxanthin, lycopene, lutein, and alpha- and beta-carotene) were measured by high-performance liquid chromatography.
RESULTS: Lymphocyte DNA 8-OHdG content was significantly higher and plasma levels of antioxidants (with the exception of lutein) were significantly lower in patients with AD compared with controls. In patients with AD, a significant inverse relationship between lymphocyte DNA 8-OHdG content and plasma levels of lycopene, lutein, alpha-carotene, and beta-carotene, respectively, was observed.
CONCLUSIONS: Markers of oxidative damage are increased in AD and correlate with decreased levels of plasma antioxidants. These findings suggest that lymphocyte DNA 8-OHdG content in patients with AD reflects a condition of increased oxidative stress related to a poor antioxidant status.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12020262     DOI: 10.1001/archneur.59.5.794

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  43 in total

Review 1.  Oxidative imbalance in Alzheimer's disease.

Authors:  Xiongwei Zhu; Hyoung-Gon Lee; Gemma Casadesus; Jesus Avila; Kelly Drew; George Perry; Mark A Smith
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

2.  Apolipoprotein E epsilon 4 is associated with an increased vulnerability to cell death in Alzheimer's disease.

Authors:  C Frey; A Bonert; T Kratzsch; G Rexroth; W Rösch; F Müller-Spahn; K Maurer; W E Müller; A Eckert
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

3.  Urinary 8-hydroxy-2-deoxyguanosine and cognitive function in Puerto Rican adults.

Authors:  Xiang Gao; Chao-Qiang Lai; Tammy Scott; Jian Shen; Tianxi Cai; Jose M Ordovas; Katherine L Tucker
Journal:  Am J Epidemiol       Date:  2010-07-09       Impact factor: 4.897

Review 4.  Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Authors:  Kristina Leuner; Kathrin Schulz; Tanja Schütt; Johannes Pantel; David Prvulovic; Virginie Rhein; Egemen Savaskan; Christian Czech; Anne Eckert; Walter E Müller
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

5.  Folate deficiency exacerbates apoptosis by inducing hypomethylation and resultant overexpression of DR4 together with altering DNMTs in Alzheimer's disease.

Authors:  Yun Wang; Shunliang Xu; Yanjun Cao; Zhaohong Xie; Chao Lai; Xiaowei Ji; Jianzhong Bi
Journal:  Int J Clin Exp Med       Date:  2014-08-15

Review 6.  Inflammation and programmed cell death in Alzheimer's disease: comparison of the central nervous system and peripheral blood.

Authors:  Beatrice Macchi; Francesca Marino-Merlo; Caterina Frezza; Salvatore Cuzzocrea; Antonio Mastino
Journal:  Mol Neurobiol       Date:  2014-01-21       Impact factor: 5.590

7.  Long-Term Intake of Dietary Carotenoids Is Positively Associated with Late-Life Subjective Cognitive Function in a Prospective Study in US Women.

Authors:  Changzheng Yuan; Elinor Fondell; Alberto Ascherio; Olivia I Okereke; Francine Grodstein; Albert Hofman; Walter C Willett
Journal:  J Nutr       Date:  2020-07-01       Impact factor: 4.798

Review 8.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012

9.  Detection and quantification of 8-hydroxy-2'-deoxyguanosine in Alzheimer's transgenic mouse urine using capillary electrophoresis.

Authors:  Cheng Zhang; Gergana Nestorova; Robert A Rissman; June Feng
Journal:  Electrophoresis       Date:  2013-07-15       Impact factor: 3.535

Review 10.  Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases.

Authors:  M Reale; N H Greig; M A Kamal
Journal:  Mini Rev Med Chem       Date:  2009-09       Impact factor: 3.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.